13.03.2019 CO.DON AG  DE000A1K0227

DGAP-News: CO.DON AG: Strategic expansion and further internationalisation


 

DGAP-News: CO.DON AG / Key word(s): Miscellaneous
CO.DON AG: Strategic expansion and further internationalisation

13.03.2019 / 13:56
The issuer is solely responsible for the content of this announcement.


CO.DON AG - Strategic expansion and further internationalisation

Berlin / Teltow, 13 March 2019 - As a result of the contacts established last year and of talks about the further internationalisation of CO.DON's business, the Executive Board is expanding its strategic planning, also to include the option of a faster entry into the US market.

Ralf Jakobs, CEO of CO.DON AG: "The fact that a strategic US financial group with global operations and great experience in healthcare and biotechnology participated in the issue of convertible bonds and warrants last year means that we are increasingly attracting the attention of major US-based investors and potential business partners. We were given to understand this very clearly at this year's BIO CEO & Investor Conference in New York. We are therefore examining the possible options for further investments and partnerships very carefully."

Also in this context CO.DON is reviewing various financing options. They also include the possibility of raising equity.

CO.DON AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells ("autologous chondrocytes"). CO.DON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated. In July 2017 CO.DON AG received central EU marketing authorisation for this product from the European Medicines Agency (EMA). The shares in CO.DON AG are listed on the Frankfurt Stock Exchange (ISIN: DE000A1K0227). Executive Board: Ralf M. Jakobs.

Further information is available from www.codon.de

Investor Relations and Press Contact:

Matthias Meißner, M.A.

Tel. +49 (0)30 240352330

Fax +49 (0)30 240352309

Email: ir@codon.de

 



13.03.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CO.DON AG
Warthestraße 21
14513 Teltow
Germany
Phone: 03328 43460
Fax: 03328 434643
E-mail: info@codon.de
Internet: www.codon.de
ISIN: DE000A1K0227
WKN: A1K022
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange

 
End of News DGAP News Service

787085  13.03.2019 

fncls.ssp?fn=show_t_gif&application_id=787085&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2012 2013 2014 2015 2016 2017 2018 2019e
Umsatzerlöse1 2,69 3,62 4,48 5,09 5,60 5,96 5,65 8,80
EBITDA1,2 -2,24 -2,50 -2,27 -2,61 -3,41 -6,73 -7,84 0,00
EBITDA-Marge3 -83,27 -69,06 -50,67 -51,28 -60,89 -112,92 -138,76 0,00
EBIT1,4 -2,38 -2,68 -2,48 -2,86 -3,65 -6,98 -8,56 0,00
EBIT-Marge5 -88,48 -74,03 -55,36 -56,19 -65,18 -117,11 -151,50 0,00
Jahresüberschuss1 -2,38 -2,68 -2,49 -2,87 -3,65 -7,05 -6,27 0,00
Netto-Marge6 -88,48 -74,03 -55,58 -56,39 -65,18 -118,29 -110,97 0,00
Cashflow1,7 -2,33 -1,56 -1,78 -2,97 -3,62 -5,88 -8,14 0,00
Ergebnis je Aktie8 -0,22 -0,24 -0,18 -0.18 -0,21 -0,36 -0,55 -0,74
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2018 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
co.don
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A1K022 2,110 51,26
KGV 2020e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,000 -6,58
KBV KCV KUV EV/EBITDA
3,02 - 9,07 -5,233
Dividende '18 in € Dividende '19e in € Div.-Rendite '18
in %
Hauptversammlung
0,00 0,00 0,00 12.06.2019
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
30.08.2019 30.04.2019
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-23,52% -43,55% -33,54% -51,94%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CO.DON AG  ISIN: DE000A1K0227 können Sie bei DGAP abrufen

Biotechnologie , A1K022 , CNWK , XETR:CNWK